Silence Therapeutics plc, LON:SLN a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announced this morning that the Company will host a Capital Markets event for investors, analysts and media at ME London Hotel, Strand, London WC2R 1HA on Tuesday 14 November between 3:00pm and 5:30pm GMT.
At the meeting, Silence will provide an update on its RNAi pipeline and proprietary technology platforms, as well as a review of the Company’s strategy. Further details will follow in due course.